Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)
India · Delayed Price · Currency is INR 1,764.00
+17.60 (1.01%)
Oct 15, 2026, 3:29 PM IST
NSE:SUNPHARMA Market Cap
NSE:SUNPHARMA has a market cap or net worth of 4.23 trillion as of October 15, 2026. It is the 567th most valuable company in the world and the 14th biggest in India. Its market cap has increased by 6.62% in one year.
Market Cap
4.23T
Enterprise Value
3.95T
Revenue
599.11B
Global Rank
Country Rank
#14 India
PE Ratio
35.00
ChartMarket Cap Chart
Since February 15, 2001, NSE:SUNPHARMA's market cap has increased from 27.61B to 4.23T, an increase of 15,228.94%. That is a compound annual growth rate of 21.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 4.23T | 2.58% |
| Dec 31, 2025 | 4.13T | -8.83% |
| Dec 31, 2024 | 4.53T | 49.78% |
| Dec 29, 2023 | 3.02T | 25.77% |
| Dec 30, 2022 | 2.40T | 18.41% |
| Dec 31, 2021 | 2.03T | 42.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 2.40T |
| Zydus Lifesciences | 1.12T |
| Laurus Labs | 1.10T |
| Cipla | 1.06T |
| Mankind Pharma | 964.35B |
| Aurobindo Pharma | 956.80B |
| Glenmark Pharmaceuticals | 633.82B |
| Alkem Laboratories | 621.86B |